Brief: Acer Therapeutics Announces Olpruva Commercial Launch Progressing Ahead Of Schedule
01/05/2023 13:46
May 1 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS ANNOUNCES OLPRUVA™ COMMERCIAL LAUNCH
PROGRESSING AHEAD OF SCHEDULE
* ACER THERAPEUTICS INC: OLPRUVA™ DRUG IN CHANNEL NOW
ANTICIPATED
IN MID-JUNE 2023
* ACER THERAPEUTICS INC: EXPECTS TO PUBLISH OLPRUVA'S LIST
PRICE,
OR WHOLESALE ACQUISITION COST (WAC), IN MID-TO-LATE MAY
* ACER THERAPEUTICS INC: ENGAGED IN DISCUSSIONS FOR OLPRUVA
WITH
PAYERS REPRESENTING A SUBSTANTIAL MAJORITY OF COVERED LIVES
Source text for Eikon: ID:nGNX67RMWm
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31